01
Overview
As of 2023, over 16 million packs of Heumann prescription medicines were distributed to patients[2]
- Therapeutic areas
- Other
- Modalities
- Generic medicinesprescription medicinesover-the-counter medicines
- Industry
- Biotech
02
Drug pipeline
1 assetResultz
Commercial- Indications
- Head lice infestation
03
Partnerships
Contracts with statutory and private health insurance companies for about 86% of their prescription medicines[2]
Beyond the preview
Go deeper on Heumann Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heumann Pharma.